LabCorp Is Scheduled to Present at the Baird’s 2020 Global Healthcare Conference Read more about LabCorp Is Scheduled to Present at the Baird’s 2020 Global Healthcare Conference
LabCorp Will Perform Antibody Test at No Charge to Accelerate COVID-19 Blood Plasma Donation Read more about LabCorp Will Perform Antibody Test at No Charge to Accelerate COVID-19 Blood Plasma Donation
LabCorp Working With Public Health Authorities on No-Charge Antibody Test Program to Accelerate COVID-19 Blood Plasma Donation Read more about LabCorp Working With Public Health Authorities on No-Charge Antibody Test Program to Accelerate COVID-19 Blood Plasma Donation
LabCorp Announces 2020 Second Quarter Results Read more about LabCorp Announces 2020 Second Quarter Results
LabCorp Receives Authorization for COVID-19 Sample Pooling Read more about LabCorp Receives Authorization for COVID-19 Sample Pooling
JLL and LabCorp team up to enable safer, healthier workplaces Read more about JLL and LabCorp team up to enable safer, healthier workplaces
LabCorp’s Insight Analytics Reports Help Healthcare Organizations Identify Trends for High-Risk Health Conditions and Improve Quality of Care Read more about LabCorp’s Insight Analytics Reports Help Healthcare Organizations Identify Trends for High-Risk Health Conditions and Improve Quality of Care
LabCorp Launches First Digital COVID-19 Service That Improves the Doctor and Patient Experience Read more about LabCorp Launches First Digital COVID-19 Service That Improves the Doctor and Patient Experience
LabCorp to Announce Second Quarter Financial Results on July 28, 2020 Read more about LabCorp to Announce Second Quarter Financial Results on July 28, 2020
Jack Meehan - Life Science Tools & Diagnostics Jack Meehan Nephron Healthcare Investment Research 646-214-0299
